Polar Capital Holdings PLC Bellus Health Inc. Transaction History

Polar Capital Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 13, 2023	BUY	$7.14 - $8.53 $25.4 Million - $30.3 Million	3,557,225 New	3,557,225 $25.6 Million
Q1 2023 May 15, 2023	BUY	$7.14 - $8.53 $3.71 Million - $4.44 Million	520,000 Added 17.12%	3,557,225 $25.6 Million
Q4 2022 Feb 14, 2023	SELL	$8.22 - $10.76 $4.11 Million - $5.38 Million	-500,000 Reduced 14.14%	3,037,225 $25 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $333,163 - $446,700	37,225 Added 1.06%	3,537,225 $37.4 Million
Q2 2022 Aug 15, 2022	BUY	$6.46 - $10.02 $1.62 Million - $2.51 Million	250,000 Added 7.69%	3,500,000 $32.3 Million
Q1 2022 May 16, 2022	BUY	$5.56 - $7.99 $6.95 Million - $9.99 Million	1,250,000 Added 62.5%	3,250,000 $22.4 Million
Q4 2021 Feb 14, 2022	SELL	$5.26 - $8.3 $3.28 Million - $5.17 Million	-623,109 Reduced 23.75%	2,000,000 $16.1 Million
Q3 2021 Nov 15, 2021	SELL	$2.7 - $6.64 $2.37 Million - $5.82 Million	-876,891 Reduced 25.05%	2,623,109 $16.1 Million
Q4 2020 Feb 16, 2021	BUY	$2.27 - $3.3 $7.95 Million - $11.6 Million	3,500,000 New	3,500,000 $10.7 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.